Phase 3 Prostate Cancer Metastatic trials recruiting now

All Prostate Cancer Metastatic trials, every phase

Other phases for Prostate Cancer Metastatic

Phase 3 Prostate Cancer Metastatic trials

• A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
  NCT06320067 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 18 locations
• ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
  NCT04916613 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 95 locations
• Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
  NCT05352178 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
  NCT06496581 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: Male · 25 locations
• Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
  NCT06136624 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 288 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.